AGL 38.89 Increased By ▲ 0.87 (2.29%)
AIRLINK 207.05 Increased By ▲ 9.69 (4.91%)
BOP 9.60 Increased By ▲ 0.06 (0.63%)
CNERGY 6.34 Increased By ▲ 0.43 (7.28%)
DCL 9.15 Increased By ▲ 0.33 (3.74%)
DFML 37.50 Increased By ▲ 1.76 (4.92%)
DGKC 99.60 Increased By ▲ 2.74 (2.83%)
FCCL 35.85 Increased By ▲ 0.60 (1.7%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.77 Increased By ▲ 0.60 (4.56%)
HUBC 129.36 Increased By ▲ 1.81 (1.42%)
HUMNL 13.70 Increased By ▲ 0.20 (1.48%)
KEL 5.47 Increased By ▲ 0.15 (2.82%)
KOSM 7.24 Increased By ▲ 0.24 (3.43%)
MLCF 45.55 Increased By ▲ 0.85 (1.9%)
NBP 60.75 Decreased By ▼ -0.67 (-1.09%)
OGDC 220.35 Increased By ▲ 5.68 (2.65%)
PAEL 40.90 Increased By ▲ 2.11 (5.44%)
PIBTL 8.49 Increased By ▲ 0.24 (2.91%)
PPL 200.00 Increased By ▲ 6.92 (3.58%)
PRL 39.69 Increased By ▲ 1.03 (2.66%)
PTC 27.25 Increased By ▲ 1.45 (5.62%)
SEARL 107.60 Increased By ▲ 4.00 (3.86%)
TELE 8.60 Increased By ▲ 0.30 (3.61%)
TOMCL 35.85 Increased By ▲ 0.85 (2.43%)
TPLP 13.70 Increased By ▲ 0.40 (3.01%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 33.20 Increased By ▲ 0.23 (0.7%)
WTL 1.69 Increased By ▲ 0.09 (5.63%)
BR100 12,033 Increased By 306.8 (2.62%)
BR30 37,314 Increased By 937.3 (2.58%)
KSE100 112,572 Increased By 3058.5 (2.79%)
KSE30 35,526 Increased By 1012.4 (2.93%)

GENEVA: The World Health Organization's vaccine advisers on Monday recommended people with weaker immune systems should be offered an additional dose of all authorised Covid-19 vaccines.

The UN health agency's Strategic Advisory Group of Experts on Immunisation (SAGE) also said over-60s who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered an additional third Covid-19 vaccine dose.

The experts stressed they were not recommending an additional so-called booster dose for the population at large.

Several Covid-19 vaccines have been given WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.

AstraZeneca antibody drug important as preventative COVID-19 therapy

It is on the verge of deciding whether to give emergency use listing to India's Bharat Biotech jab.

SAGE held a four-day meeting last week to review the latest information and data on a range of vaccines for Covid-19 and other diseases.

"SAGE recommended that moderately and severely immunocompromised persons should be offered an additional dose of all WHO EUL (emergency use listing) Covid-19 vaccines as part of an extended primary series," the group said.

"These individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease."

It also said that for people fully immunised with Sinovac and Sinopharm vaccines, an additional third dose of the same jab "should be offered to persons aged 60 and above".

A different vaccine "may also be considered based on vaccine supply and access considerations".

SAGE added that when implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups.

Comments

Comments are closed.